D Fink Selected Research

D Fink Research Topics

Disease

16	Neoplasms (Cancer) 10/2018 - 04/2000
8	Ovarian Neoplasms (Ovarian Cancer) 02/2016 - 04/2000
7	Breast Neoplasms (Breast Cancer) 01/2008 - 02/2001
3	Overactive Urinary Bladder (Overactive Bladder) 04/2012 - 01/2006
3	Carcinoma (Carcinomatosis) 09/2007 - 01/2000
3	Melanoma (Melanoma, Malignant) 01/2007 - 08/2001
2	Neoplasm Metastasis (Metastasis) 03/2013 - 01/2007
2	Stress Urinary Incontinence 04/2012 - 01/2002
2	Residual Neoplasm 11/2005 - 01/2000
1	Peritoneal Neoplasms 01/2018
1	Body Weight (Weight, Body) 04/2015
1	Lymphedema (Milroy Disease) 01/2013
1	Lymphatic Metastasis 06/2012
1	Uterine Cervical Neoplasms (Cancer of the Cervix) 06/2012
1	Uterine Cervical Dysplasia 05/2012
1	Hemophilia A (Haemophilia) 11/2011
1	Anemia 10/2011
1	Glioblastoma (Glioblastoma Multiforme) 06/2011
1	Q Fever (Fever, Q) 04/2010
1	Stroke (Strokes) 12/2007
1	Pre-Eclampsia (Preeclampsia) 01/2007
1	Endometriosis 01/2007
1	Cysts 03/2006
1	Radiation Injuries (Radiation Sickness) 03/2006
1	Endometrial Neoplasms (Endometrial Cancer) 01/2006
1	Ascites 11/2005
1	Thyroid Diseases (Thyroid Disease) 11/2005
1	Thyroid Neoplasms (Thyroid Cancer) 11/2005
1	Chronic Disease (Chronic Diseases) 10/2005
1	Cardiac Tamponade 11/2004
1	Turcot syndrome 10/2003
1	Adenocarcinoma 10/2003
1	Tuberculosis (Tuberculoses) 05/2003
1	Rheumatoid Arthritis 05/2003
1	Necrosis 04/2002

Drug/Important Bio-Agent (IBA)

3	Proteins (Proteins, Gene)FDA Link 06/2011 - 10/2000
3	PlatinumIBA 11/2005 - 01/2000
3	Antineoplastic Agents (Antineoplastics)IBA 10/2003 - 10/2002
2	Hormones (Hormone)IBA 04/2015 - 03/2013
2	Botulinum Toxins (Botulinum Toxin)IBA 04/2012 - 01/2006
2	Pharmaceutical PreparationsIBA 06/2011 - 04/2000
2	Estrogens (Estrogen)FDA Link 01/2007 - 02/2001
2	Biological ProductsIBA 01/2006 - 08/2001
1	LigandsIBA 10/2018
1	Coloring Agents (Dyes)IBA 03/2013
1	Erythropoietin FDA Link 10/2011
1	Temozolomide (Temodar)FDA LinkGeneric 06/2011
1	AntibodiesIBA 04/2010
1	Anti-Bacterial Agents (Antibiotics)IBA 04/2010
1	tissue polypeptide specific antigenIBA 01/2009
1	Tamoxifen FDA LinkGeneric 01/2008
1	A 19IBA 12/2007
1	RNA (Ribonucleic Acid)IBA 09/2007
1	Epidermal Growth Factor (EGF)IBA 09/2007
1	Fibroblast Growth Factors (Fibroblast Growth Factor)IBA 09/2007
1	Phosphotransferases (Kinase)IBA 09/2007
1	Receptor Protein-Tyrosine Kinases (Tyrosine Kinase Receptors)IBA 09/2007
1	tyrosine receptor (receptor, tyrosine)IBA 09/2007
1	Trastuzumab (Herceptin)FDA Link 09/2007
1	Thalidomide (Thalomid)FDA Link 01/2007
1	Dacarbazine (DIC)FDA LinkGeneric 01/2007
1	Interferon-alpha (Interferon Alfa)IBA 01/2007
1	Galectin 4 (LGALS4)IBA 03/2006
1	OligonucleotidesIBA 03/2006
1	Acetylcholine (Acetylcholine Chloride)FDA Link 01/2006
1	Type A Botulinum Toxins (Botox)FDA Link 01/2006
1	IodineIBA 11/2005
1	vasectrin IIIIBA 11/2005
1	Contraceptive Agents (Contraceptives)IBA 10/2005
1	SteroidsIBA 11/2004
1	DNA (Deoxyribonucleic Acid)IBA 10/2003
1	tallimustineIBA 10/2003
1	brostallicinIBA 10/2003
1	Methotrexate (Mexate)FDA LinkGeneric 05/2003
1	Oxygen (Dioxygen)IBA 04/2002
1	CalciumIBA 09/2001
1	Taxoids (Taxanes)IBA 08/2001
1	Type I DNA Topoisomerases (Topoisomerase I)IBA 08/2001
1	PoisonsIBA 08/2001
1	CaspasesIBA 08/2001

Therapy/Procedure

10	Therapeutics 11/2011 - 04/2000
7	Drug Therapy (Chemotherapy) 01/2018 - 01/2000
2	Intravesical Administration 04/2012 - 01/2006
1	Hyperthermic Intraperitoneal Chemotherapy 02/2016
1	Radiotherapy 01/2013
1	Lymph Node Excision (Lymph Node Dissection) 01/2013
1	Contraindications 06/2012
1	Pelvic Exenteration 06/2012
1	Electrosurgery 05/2012
1	Suburethral Slings (Tension-Free Vaginal Tape) 04/2012
1	Erythrocyte Transfusion 10/2011
1	Cardiopulmonary Bypass (Heart-Lung Bypass) 12/2007
1	Immunotherapy 01/2007
1	Hyperbaric Oxygenation 03/2006
1	Injections 01/2006
1	Nerve Block (Nerve Blocks) 01/2006
1	Cytoreduction Surgical Procedures 11/2005
1	Aftercare (After-Treatment) 10/2003
1	Operative Surgical Procedures 01/2002
1	Heterologous Transplantation (Xenotransplantation) 08/2001